Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$0.36 - $0.65 $13,915 - $25,124
-38,653 Reduced 96.66%
1,337 $0
Q1 2024

May 07, 2024

SELL
$0.42 - $1.38 $164 - $539
-391 Reduced 0.97%
39,990 $27,000
Q4 2023

Feb 01, 2024

SELL
$0.3 - $0.63 $100 - $211
-335 Reduced 0.82%
40,381 $22,000
Q3 2023

Nov 07, 2023

BUY
$0.58 - $1.47 $357 - $905
616 Added 1.54%
40,716 $24,000
Q2 2023

Aug 07, 2023

SELL
$1.11 - $1.74 $304 - $476
-274 Reduced 0.68%
40,100 $52,000
Q1 2023

May 02, 2023

SELL
$1.66 - $3.67 $66,604 - $147,251
-40,123 Reduced 49.84%
40,374 $71,000
Q4 2022

Jan 30, 2023

BUY
$2.77 - $5.07 $130 - $238
47 Added 0.06%
80,497 $253,000
Q3 2022

Nov 08, 2022

BUY
$4.27 - $6.39 $845 - $1,265
198 Added 0.25%
80,450 $394,000
Q2 2022

Aug 04, 2022

SELL
$3.28 - $6.21 $14,730 - $27,889
-4,491 Reduced 5.3%
80,252 $332,000
Q1 2022

May 05, 2022

BUY
$5.23 - $7.82 $324 - $484
62 Added 0.07%
84,743 $492,000
Q4 2021

Feb 02, 2022

SELL
$7.29 - $10.97 $217,081 - $326,664
-29,778 Reduced 26.02%
84,681 $635,000
Q3 2021

Nov 02, 2021

BUY
$9.01 - $12.01 $5,748 - $7,662
638 Added 0.56%
114,459 $1.03 Million
Q2 2021

Aug 02, 2021

SELL
$10.17 - $12.64 $120,514 - $149,784
-11,850 Reduced 9.43%
113,821 $1.36 Million
Q4 2020

Feb 08, 2021

BUY
$9.23 - $18.18 $132,450 - $260,883
14,350 Added 12.89%
125,671 $1.96 Million
Q2 2020

Aug 07, 2020

BUY
$6.21 - $11.83 $65,205 - $124,215
10,500 Added 10.41%
111,321 $997,000
Q1 2020

May 06, 2020

BUY
$5.05 - $8.85 $505 - $885
100 Added 0.1%
100,821 $642,000
Q4 2019

Feb 05, 2020

SELL
$8.03 - $11.7 $195,931 - $285,480
-24,400 Reduced 19.5%
100,721 $843,000
Q3 2019

Nov 07, 2019

BUY
$9.05 - $12.22 $10,860 - $14,664
1,200 Added 0.97%
125,121 $1.13 Million
Q2 2019

Aug 09, 2019

BUY
$8.75 - $13.03 $154,000 - $229,328
17,600 Added 16.55%
123,921 $1.34 Million
Q1 2019

May 08, 2019

SELL
$7.72 - $12.81 $3,474 - $5,764
-450 Reduced 0.42%
106,321 $1.01 Million
Q4 2018

Feb 08, 2019

SELL
$9.51 - $16.6 $134,566 - $234,890
-14,150 Reduced 11.7%
106,771 $1.23 Million
Q3 2018

Nov 07, 2018

BUY
$13.05 - $19.05 $6,525 - $9,525
500 Added 0.42%
120,921 $2.05 Million
Q2 2018

Aug 10, 2018

BUY
$13.9 - $19.8 $284,950 - $405,900
20,500 Added 20.52%
120,421 $1.71 Million
Q1 2018

May 10, 2018

BUY
$16.7 - $26.35 $14,195 - $22,397
850 Added 0.86%
99,921 $1.9 Million
Q4 2017

Feb 13, 2018

SELL
$11.6 - $17.35 $164,244 - $245,658
-14,159 Reduced 12.5%
99,071 $1.63 Million
Q3 2017

Nov 06, 2017

BUY
$8.4 - $15.0 $311,052 - $555,450
37,030 Added 48.6%
113,230 $1.7 Million
Q2 2017

Aug 11, 2017

BUY
N/A
76,200
76,200 $671,000

Others Institutions Holding SGMO

About SANGAMO THERAPEUTICS, INC


  • Ticker SGMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 156,552,992
  • Market Cap $193M
  • Description
  • Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...
More about SGMO
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.